PMID: 8952007Nov 14, 1996Paper

Interactions of exendin-(9-39) with the effects of glucagon-like peptide-1-(7-36) amide and of exendin-4 on arterial blood pressure and heart rate in rats

Regulatory Peptides
J M BarragánE Blázquez

Abstract

This study was designed to determine the interactions of peptide exendin-(9-39) with the effect of glucagon-like peptide-1-(7-36) (GLP-1 (7-36)) amide and of exendin-4 on arterial blood pressure and heart rate in the rat. Both GLP-1 (7-36) amide and exendin-4 produced a dose-dependent increase in systolic, diastolic and mean arterial blood pressure, as well as in heart rate, although the effect of exendin-4 was more prolonged. These data indicate a longer functional half-life in vivo for exendin-4 as compared to GLP-1 (7-36) amide, which may have therapeutical applications. The antagonist effect of exendin-(9-39) on these cardiovascular parameters was also tested with 3000 ng of exendin-(9-39) intravenously administered 5 min before i.v. injection of 10 ng of either GLP-1 (7-36) amide or exendin-4. Under these experimental conditions the effect of the latter two peptides on arterial blood pressure and heart rate was blocked. By contrast, single administration of exendin-(9-39) did not modify cardiovascular parameters. These findings indicate that exendin-4 is an agonist and that exendin-(9-39) is an antagonist of the action of GLP-1 (7-36) amide on arterial blood pressure and heart rate. Therefore, the action of GLP-1 (7-36) am...Continue Reading

References

Jul 4, 1968·The New England Journal of Medicine·W W ParmleyE H Sonnenblick
Jan 1, 1995·The Journal of Clinical Investigation·Z WangS R Bloom
Mar 1, 1996·Journal of Neurochemistry·E AlvarezE Blázquez

❮ Previous
Next ❯

Citations

Mar 5, 1999·Molecular Neurobiology·E BlázquezJ A Zueco
Oct 15, 2008·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Thomas Jax
Dec 12, 2001·Toxicon : Official Journal of the International Society on Toxinology·Steven D Aird
Apr 14, 2009·International Journal of Obesity : Journal of the International Association for the Study of Obesity·H J Grill, M R Hayes
Mar 27, 2009·Metabolic Syndrome and Related Disorders·Kevin D LaugeroDavid G Parkes
Mar 4, 2010·American Journal of Physiology. Endocrinology and Metabolism·Diego Pérez-TilveFederico Mallo
Apr 3, 2001·American Journal of Respiratory and Critical Care Medicine·E VaraE Blázquez
Feb 11, 2012·Endocrine Reviews·John R Ussher, Daniel J Drucker
May 28, 2013·Endocrine Journal·Daisuke SatoHiroshi Maegawa
Jan 21, 2012·The Review of Diabetic Studies : RDS·Cendrine Cabou, Rémy Burcelin
Aug 9, 2013·The Journal of Endocrinology·Franca S Angeli, Richard P Shannon
Jun 3, 2014·Reviews in Endocrine & Metabolic Disorders·Adam G GoodwillJohnathan D Tune
Mar 20, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Lovisa NalinMarianne Jensen-Waern
Jun 9, 2014·Current Hypertension Reports·Pelbreton C BalfourKeith C Ferdinand
Aug 12, 2014·Journal of Endocrinological Investigation·G MuscogiuriA Colao
Jan 16, 1996·Regulatory Peptides·J P Raufman
Dec 17, 2014·Expert Opinion on Drug Safety·Agostino Consoli, Gloria Formoso
Mar 17, 2010·Physiology & Behavior·Matthew R HayesScott E Kanoski
Oct 20, 2009·Frontiers in Neuroendocrinology·Harvey J Grill
Mar 2, 2016·Clinical Therapeutics·Stephen Brunton, Jaime A Davidson
Jun 16, 2015·Journal of Diabetes Research·Jixin ZhongSanjay Rajagopalan
Jul 13, 2004·Peptides·Naciye Isbil-Buyukcoskun, Guldal Gulec
Jan 31, 2018·Journal of the Endocrine Society·Vittorio CacciatoriEnzo Bonora
Jul 10, 2018·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Ruben RodriguezRudy M Ortiz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.